PPB - Services

Complaints, Feedback and Enquiry

Rejected Clinical Trials

Rejected Clinical Trials

Protocol No. Study Title Date of protocol Study Drug Disease condition Product Type Co-ordinating Investigator Participants in Kenya Multiple site names
ECCT/16/06/02 A Randomized Comparison of Three Regimens of Chemotherapy with Compatible Antiretroviral Therapy for Treatment of Advanced AIDS-KS in Resource-Limited Settings 07/08/2012 Paclitaxel, Bleomycin,Vincristine and Etoposide Advanced AIDS-KS ; Chemical: Paclitaxel, Bleomycin,Vincristine and Etoposide The National Institute of Allergy and Infectious Diseases (NIAID) The National Cancer Institute (NCI) National Institute of Dental Craniofacial Research (NIDCR) Contact: Dr. Kevin Cain Kisumu CRS Contact: P.O BOX 1578-40100 Kenya, Uganda, South Africa, Malawi, Peru and Zimbabwe
ECCT/15/11/03 A Phase 3 Open‚ÄêLabel Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of the Combination of Moxifloxacin plus PA‚Äê824 plus Pyrazinamide after 4 and 6 months of Treatment in Adult Subjects with Drug‚ÄêSensitive Smear‚ÄêPositive Pulmonary Tuberculosis and after 6 months of Treatment in Adult Subjects with Multi‚ÄêDrug Resistant, Smear‚ÄêPositive Pulmonary Tuberculosis 14/04/2014 PA-824 Tuberculosis Biologicals; Toxoid; Chemical: Avelox Global Alliance for TB Drug Development Contact: Dr. Daniel E. Everitt, MD KEMRICDC  Contact: 1578-40100 Kenya, Tanzania, Uganda, South Africa, Mozambique, Zambia, USA, Peru, Thailand, Phillipines, China, Russia, Ukraine, Malaysia, Brazil, Haiti